Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Medarex and diaDexus expand collaboration into cancer antibody therapeutics

Sep. 22, 2004

Expanded indication for Eloxatin for early stage colon cancer treatment

Sep. 21, 2004

FDA accepts sBLA for expanded use of Bexxar

Sep. 21, 2004

Isis licenses second antisense anticancer drug candidate to Lilly

Sep. 21, 2004

New antitumor pregnene derivative isolated from gorgonian species

Sep. 21, 2004

Pfizer presents new TGF-beta type II receptor kinase inhibitors

Sep. 21, 2004

New antitumor agents prepared and tested at Dr. Reddy's

Sep. 21, 2004

License termination agreement returns LEP and LED rights to NeoPharm

Sep. 21, 2004

New antitumor agents prepared and tested at Servier

Sep. 20, 2004

Aventis describes cyclic urea-based inhibitors of IGF-1R and other kinases

Sep. 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.